Cochlear Limited Stock Performance
| CHEOF Stock | USD 144.54 5.54 3.99% |
The firm shows a Beta (market volatility) of -0.81, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cochlear are expected to decrease at a much lower rate. During the bear market, Cochlear is likely to outperform the market. At this point, Cochlear Limited has a negative expected return of -0.37%. Please make sure to confirm Cochlear's maximum drawdown, and the relationship between the information ratio and daily balance of power , to decide if Cochlear Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cochlear Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 609.6 M | |
| Total Cashflows From Investing Activities | -138.9 M |
Cochlear |
Cochlear Relative Risk vs. Return Landscape
If you would invest 19,124 in Cochlear Limited on December 4, 2025 and sell it today you would lose (4,670) from holding Cochlear Limited or give up 24.42% of portfolio value over 90 days. Cochlear Limited is currently producing negative expected returns and takes up 4.12% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than Cochlear, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cochlear Target Price Odds to finish over Current Price
The tendency of Cochlear Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 144.54 | 90 days | 144.54 | close to 99 |
Based on a normal probability distribution, the odds of Cochlear to move above the current price in 90 days from now is close to 99 (This Cochlear Limited probability density function shows the probability of Cochlear Pink Sheet to fall within a particular range of prices over 90 days) .
Cochlear Price Density |
| Price |
Predictive Modules for Cochlear
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cochlear Limited. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cochlear Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cochlear is not an exception. The market had few large corrections towards the Cochlear's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cochlear Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cochlear within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | -0.81 | |
σ | Overall volatility | 12.66 | |
Ir | Information ratio | -0.06 |
Cochlear Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cochlear for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cochlear Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cochlear Limited generated a negative expected return over the last 90 days | |
| Cochlear Limited has high historical volatility and very poor performance |
Cochlear Fundamentals Growth
Cochlear Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cochlear, and Cochlear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cochlear Pink Sheet performance.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 9.05 B | |||
| Shares Outstanding | 65.78 M | |||
| Price To Earning | 42.16 X | |||
| Price To Book | 8.08 X | |||
| Price To Sales | 5.69 X | |||
| Revenue | 1.65 B | |||
| EBITDA | 475.4 M | |||
| Cash And Equivalents | 629.3 M | |||
| Cash Per Share | 9.57 X | |||
| Total Debt | 253.9 M | |||
| Debt To Equity | 0.15 % | |||
| Book Value Per Share | 25.63 X | |||
| Cash Flow From Operations | 376.5 M | |||
| Earnings Per Share | 3.05 X | |||
| Total Asset | 2.47 B | |||
| Retained Earnings | 304 M | |||
| Current Asset | 543 M | |||
| Current Liabilities | 251 M | |||
About Cochlear Performance
By analyzing Cochlear's fundamental ratios, stakeholders can gain valuable insights into Cochlear's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cochlear has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cochlear has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.Things to note about Cochlear Limited performance evaluation
Checking the ongoing alerts about Cochlear for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cochlear Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cochlear Limited generated a negative expected return over the last 90 days | |
| Cochlear Limited has high historical volatility and very poor performance |
- Analyzing Cochlear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cochlear's stock is overvalued or undervalued compared to its peers.
- Examining Cochlear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cochlear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cochlear's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cochlear's pink sheet. These opinions can provide insight into Cochlear's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cochlear Pink Sheet analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |